Evaluation of Pediatric eCART Implementation
- Conditions
- Pediatric ALLSepsis
- Registration Number
- NCT06771830
- Lead Sponsor
- University of Wisconsin, Madison
- Brief Summary
This is a study comparing 3 years of retrospective data (pre-implementation) to 2 years of prospective data after the implementation of a pediatric version of Electronic Cardiac Arrest Risk Triage (pediatric eCART), a clinical decision support (CDS) tool that uses electronic health records (EHR) to identify patients with high risk for life threatening outcomes. Up to 30,000 encounters with pediatric patients will be assessed. Acceptability of the pediatric eCART intervention will also be measured from pediatric nurse clinicians.
- Detailed Description
Pediatric eCART draws upon readily available EHR data and rapidly quantifies disease severity, predicting the likelihood of critical illness onset. Currently, no consistently available system continuously tracks the risk of critical illness in children admitted to UW Health. While AFCH has an implementation of Pediatric Early Warning Scores (PEWS) available for risk monitoring, internal reports indicate limited usage. Therefore, AFCH/UW Health clinicians or care providers do not have a reliable mechanism to risk-stratify patients for effective clinical decision-making.
This proposal leverages the AgileMD clinical decision support engine and a machine learning analytic developed in a dataset of over 30,000 patients. Pediatric eCART was explicitly designed to draw attention to patients at increased risk of deterioration and optimize patient management, including the timing of and need for ICU-level care.
Preliminary studies indicate that pediatric eCART implementation at the University of Chicago has led to improved outcomes. Similar improvements among children admitted to UW Health will lead to decreased morbidity and mortality among the pediatric population.
Further, a significant gap in understanding of nurse acceptance of data-driven CDS tools remains. Nurses are the largest workforce of clinicians in the health system and play a primary role in the detection of clinical deterioration as the clinicians that spend the most time observing and assessing patients; however, AI-driven CDS acceptability has not been measured to assess nurse acceptance of these emerging tools. Acceptability is essential to increase sustained use and to decrease suboptimal outcomes such as alert fatigue or increased cognitive load so that these tools ultimately mediate nurse well-being. One study assessed nurse perceptions of the usefulness of a sepsis early warning system and found that less than half of nurses perceived the alerts to be helpful and only a third of nurses reported that the alerts impacted patient care. Understanding nurse acceptance will inform AgileMD's design strategies to foster uptake and use so that predictive tools may be leveraged to improve the cognitive burden of nurse clinicians. In the end, the study will evaluate pediatric eCART on two pediatric groups: (1) screened pediatric patients; (2) pediatric nurse clinician end-users.
Study Design: This is a pre- and post- interventional study of a machine learning algorithm integrated into the electronic health record as a clinical decision support tool. The "pre" participants are hospitalized children (less than 18 years old) who were admitted to UW Health between January 1, 2022, and the date of pediatric eCART implementation in 2025. Pediatric eCART scores will be retrospectively calculated for the "pre" participants by feeding a patient's labs and vital sign observation into the pediatric eCART tool. The "post" participants are hospitalized children (less than18 years old) who will be admitted to UW Health within the two years following pediatric eCART implementation (expected 2025-2027). Pediatric eCART scores will be calculated in real-time for these patients.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 30000
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method In Hospital Mortality assessed through hospital stay (typically up to 5 days on average, but may be over 60 days) Intensive Care Unit (ICU) free days up to 28 days Defined as the number of days patients were both alive and discharged from the ICU out of the first 28 days of hospitalization. Because death is biased toward fewer ICU days and is a competing outcome, patients who die prior to day 28 are assigned with 0 ICU-free days.
- Secondary Outcome Measures
Name Time Method Number of ICU transfers assessed through hospital stay (typically up to 5 days on average, but may be over 60 days) Median 30-day Ventilator-Free Days assessed through hospital stay (typically up to 5 days on average, but may be over 60 days) Summary of Critical Events assessed through hospital stay (typically up to 5 days on average, but may be over 60 days) Summary of critical events, including mechanical ventilation, vasoactive administration, or death, reported by participant count.
Total Hospital Length of Stay (LOS) assessed through hospital stay (typically up to 5 days on average, but may be over 60 days) Reported in days
Usability of Pediatric eCART: System Usability Scale (SUS) score Surveys automatically sent to nurses within a week of eCART interface, responses collected up to 1 month SUS is a 10-item survey scored on a 5 point response scale from strongly disagree to strongly agree. Scores are transformed to a scale from 0-100 where higher scores are indicative of better system usability.
Acceptability of Pediatric eCART: Perceived Usefulness Scale Surveys automatically sent to nurses within a week of eCART interface, responses collected up to 1 month The Perceived Usefulness scale uses a 7-point response scale from 0 (extremely unlikely) to 6 (extremely likely) for a total possible range of scores from 0 to 36, higher scores indicate higher perceived usefulness.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
American Family Children's Hospital
🇺🇸Madison, Wisconsin, United States